Introduction
A variety of nanomaterials have been widely investigated for theranostic applications including iron oxide nanoparticles (IONPs), [1] gold nanoparticles (AuNPs), [2] silica nanoparticles (SiNPs), [3] upconversion nanoparticles (UCNPs), [4] polymeric nanoparticles, [5] and emerging 2D nanomaterials. [6] [7] [8] Molybdenum disulfide (MoS 2 ), one of the 2D graphene analogues, and photoacoustic tomography (PAT), and target-specific photothermal therapy (PTT) (Figure 1) . HA is one of the best natural biopolymers and has been widely used for target-specific drug delivery via HA receptors such as cluster determinant 44 (CD44), hyaluronan receptor for endocytosis (HARE), and lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) usually over-expressed on various tumor cells. [23, 24] As shown in Figure 1b , HA-MoS 2 conjugate prepared by facile disulfide bond formation between MoS 2 and thiolated HA (HA-SH) can bind to the HA receptors over-expressed on tumor cells. After cellular uptake by the HA receptor-mediated endocytosis, the disulfide bond of HA-MoS 2 conjugate can be cleaved in the cytoplasm due to the reducing environment of low pH and glutathione (GSH) during the endosomal escape. [25] While HA naturally degrades by hyaluronidases of Hyal-1 and Hyal-2, [26] the following aggregation of unstable MoS 2 nanoparticle in the cytoplasm can contribute to enhance the optical signal and the photothermal effect in the tumor cells for effective cancer theranosis.
Results and Discussion

Preparation and Characterization of HA-MoS 2 Conjugates
MoS 2 nanoparticle was simply prepared by the solvothermal and exfoliation process. [27] Bulk MoS 2 powder was dispersed in 1-methy-2-pyrrolidinone (NMP) following the probe-sonication. After keeping at 140 °C with vigorous stirring, the brownish yellow MoS 2 nanoparticle could be collected by centrifugation and dialysis against deionized (DI) water. HA was chemically modified with cystamine to introduce thiol groups, which was attached to the MoS 2 surface via disulfide bond formation. Atomic force microscope (AFM) analysis clearly showed the monolayer morpho logies of both MoS 2 nanomaterials and HA-MoS 2 conjugates (Figure 2a) . Transmission electron microscope (TEM) was used to analyze the morphology and the particle size of MoS 2 and HA-MoS 2 conjugates (Figure 2b ). The lateral size was increased after HA conjugation due to the surface wrapping of MoS 2 nanoparticle with HA. [28] The individual MoS 2 nanomaterials had a mean particle size of 61.9 nm www.advancedsciencenews.com www.advhealthmat.de with 0.615 nm of thickness corresponding to the thickness of monolayer of MoS 2 . Both the size and thickness of HA-MoS 2 conjugates were slightly increased to 85.9 and 1.10 nm, respectively. In addition, high-resolution TEM (HR-TEM) was performed to observe the crystal structure. The inset of Figure 2b shows the uniform (100) plane of each sample. According to the dynamic light scattering (DLS) analysis, the hydrodynamic size of MoS 2 nanoparticle was ≈129 ± 21.2 nm in phosphate buffer saline (PBS) and the size of HA-MoS 2 conjugate was ≈200 ± 75.31 nm (Figure 2c ), which were well matched with the results from TEM and AFM. After 7 days, however, the particle size of MoS 2 increased to ≈657 ± 153.4 nm due to the aggregation and stacking, whereas that of HA-MoS 2 conjugate only slightly increased to ≈264 ± 62.11 nm without aggregation (see the inset of Figure 2c and Figure S1 , Supporting Information). Fourier transform-infrared spectroscopy (FT-IR) analysis showed the dominant HA peaks from HA-MoS 2 conjugates. The peak of HA-SH was diminished after conjugation to MoS 2 nanoparticle with thiol S-H stretch (2500 cm −1 ), carboxylic acid O-H stretch (3400 cm −1 ), C=C stretch (1650 cm −1 ), ether -C-O-C-(1100 cm −1 ), and alkene sp 2 C-H bend at 1000 cm −1 (Figure 2e) . Especially, the peak of S-H disappeared reflecting the disulfide bond formation. In addition, X-ray photoelectron spectroscopy (XPS) of HA-MoS 2 conjugate showed the covalent functionalization between HA-SH and MoS 2 nanomaterials. The atomic ratio of Mo to S increased from 1:2 to 1:6.67 after conjugation of MoS 2 nanoparticle with HA-SH. [29] The binding energy peak of Mo 3d 5/2 and Mo 3d 3/2 appeared at 232.6 and 229.4 eV, whereas that of S 2p 3/2 and S 2p 1/2 appeared at 163.0 and 161.8 eV, respectively. In comparison with the previous report on XPS analysis of MoS 2 , both Mo 3d and S 2p peaks showed no significant change after conjugation with HA. In other words, HA did not change the innate 2H structure of MoS 2 . [9] Additionally, the large oxidation peak of S 2p was observed at 168.1 eV, corresponding to the sulfate of HA by the exposure to ambient condition (Figure 2f,g ). [30] Raman spectroscopy of HA-MoS 2 conjugates also showed similar pattern with the previously reported monolayer MoS 2 . [27] E 2g (384 cm −1 ) and A 1g (408 cm −1 ) peaks were detected in Figure S2 in the Supporting Information. All these results confirmed the successful synthesis of monolayer MoS 2 and functionalization of HA onto MoS 2 nano particle, showing better physiological stability. Figure 3a shows UV-vis spectroscopy of MoS 2 nanosheets exhibiting two absorption (excitation) bands at 610 and 654 nm. These bands might correspond to the direct transition at κ point by spin-orbit coupling of valence band. [31] The excitation bands were diminished after sonicating nanosheets to nanoparticles as reported elsewhere. [24] The PL of both MoS 2 and HA-MoS 2 conjugates was also analyzed under UV light illumination (Figure 3b ). The peak of PL intensity at each wavelength was shifted to a longer wavelength with increasing excitation wavelength. Remarkably, we could observe upconversion fluorescence of HA-MoS 2 conjugates by excitation at the NIR region (Figure 3c ). The upconverted PL intensity was relatively lower than that of downconversion fluorescence. The upconversion emission wavelength of HA-MoS 2 conjugates (525 nm) was not changed after excitation at various wavelengths from 650 to 800 nm, showing the stronger PL intensity at the higher NIR wavelength. This extraordinary optical property might be ascribed to anti-Stokes PL at the κ point where the direct exciton transition occurs. [32] These unique optical properties of MoS 2 were hardly affected by HA modification like other wrapping polymers on the MoS 2 surface as reported elsewhere. [30, 31] On the basis of these results, we carried out confocal microscopy of HA-MoS 2 conjugates uptaken into HCT116 cells at various excitation wavelengths (Figure 3d ). We could observe multicolor fluorescence of blue, green, yellow, and red from the cells at different wavelength. There were some spots with exceptionally strong PL intensity in the cytoplasm due to the aggregation of MoS 2 nanomaterials in the cells, whereas they were not observed in the bright field image (Figure 3e ).
Optical Properties of HA-MoS 2 Conjugates
In addition, MoS 2 showed excellent photoacoustic (PA) characteristics. Figure 3f shows PA signals by converting pulsed NIR laser into ultrasonic emission. The PA signals of both MoS 2 and HA-MoS 2 conjugates decreased with increasing wavelength. MoS 2 without HA conjugation showed higher signals in all range of wavelength than HA-MoS 2 conjugates, likely due to the thermal vibration broadening of HA chain. The heat generated by NIR laser illumination might diffuse from MoS 2 to HA chain by heat transport, which might diminish the PA signals. [33] To assess the photothermal property of HA-MoS 2 conjugates, the temperature of HA-MoS 2 conjugate solution was measured at various concentrations of HA-MoS 2 conjugates under continuous NIR laser illumination. Owing to the efficient light-to-heat conversion of HA-MoS 2 conjugates, the solution temperature was increased with increasing NIR exposure times and conjugate concentrations. At a concentration of 200 µg mL −1 , the solution temperature increased more than 25 °C by NIR laser illumination for 10 min. This temperature increase over 43 °C was regarded enough for photothermal ablation of cancer cells (Figure 3g ). [28] Figure S3 in Supporting Information showed the photothermal conversion efficiency and the photothermal stability of HA-MoS 2 conjugates. The photothermal conversion efficiency of HA-MoS 2 conjugates was calculated to be 11.5%, which was slightly lower than that of PEG-MoS 2 (27.6%) and MoS 2 -CS (24.4%). [15, 18] The lower photothermal conversion efficiency of HA-MoS 2 conjugates might be ascribed to the smaller particle size and the higher PL at the NIR region than those of MoS 2 nanoflakes in the PEG-MoS 2 and MoS 2 -CS of the previous reports.
In Situ Disulfide Cleavage after HA Receptor-Mediated Endocytosis
The effect of HA conjugation was assessed on the physiological stability of MoS 2 nanomaterials, which is the most important characteristic for all nanoplatforms used in circulating systems. [34] The conjugation of MoS 2 with HA could prevent the stacking of MoS 2 nanomaterials by electrostatic repulsion between HA chains, making the conjugates stable. Since exocytosis frequently occurs in case of stable nanoparticles, the aggregation of nanoparticles in the cytoplasm can prevent their exocytosis with the increased size. [35] In addition, the nanoparticle aggregation can cause the redshift of absorption wavelength, resulting in high phothothermal efficiency for the NIR laser. [33] To take advantages of these characteristics, we assessed the cleavage of disulfide bonding in HA-MoS 2 conjugates and the resulting aggregation in the intracellular reducing environment with glutathione and low pH. [25] In order for that, HA-MoS 2 conjugates were treated with tris(2-carboxyethyl)phosphine (TCEP) as a reducing agent in PBS. According to DLS analysis (Figure 4a) , the hydrodynamic size increased from 329.8 ± 66.95 to 404.9 ± 64.71 nm at 24 h www.advancedsciencenews.com www.advhealthmat.de posttreatment of TCEP. The HA-MoS 2 conjugates were well dispersed in PBS, but MoS 2 nanomaterials cleaved from HA-MoS 2 conjugates were aggregated in PBS after TCEP treatment (see the inset of Figure 4a ). The surface charge was also changed from −17.85 ± 13.1 to −6.77 ± 8.82 mV, which was similar with the value of MoS 2 in PBS (Figures 2d and 4b) . These results revealed the full cleavage of HA-MoS 2 conjugates by TCEP and the aggregation of MoS 2 nanomaterials. In addition, the change of photothermal effect was assessed before and after cleavage of disulfide bonding. In the presence of TCEP, the photothermal effect was slightly enhanced due to the aggregation of MoS 2 ( Figure 4c ). The aggregates of MoS 2 nanomaterials after disulfide bond cleavage showed higher NIR absorbing property than that of HA-MoS 2 conjugates which might be attributed to the size-dependent optical extinction coefficient change of nanoparticles. [36] [37] [38] After that, we carried out in vitro confocal microscopy to observe the disulfide bond cleavage in the cytoplasm (Figure 4d ,e). After incubation of HCT116 cells (human colon carcinoma) with Hilyte647-labeled HA-MoS 2 conjugates for 5 min, the fluorescence of both HA (red) and MoS 2 (green) appeared to be merged in the cytoplasm (Figure 4d ). However, after incubation for 24 h, the fluorescence was separated to red (HA) and green (MoS 2 ), reflecting the apparent cleavage of disulfide bonding between HA and MoS 2 ( Figure 4e ). In addition, we could observe some green aggregates in the cells, which were in accordance with some big fluorescence spots observed in Figure 3d . From in vitro bioimaging results in Figures 3 and 4 , we could confirm the feasibility of HA-MoS 2 conjugates as a bimodal imaging contrast agent for both fluorescence and PA imaging. Before in vivo experiments, we carried out confocal imaging to assess the HA receptor-mediated endocytosis of HA-MoS 2 conjugates in HCT116 and B16F10 cells with highly expressed HA receptors and HEK293 cells without HA receptors after preincubation with an excess amount of HA. [23, 24, 28] Figure 4f ,g shows the effect of HA preincubation on the HA receptor-mediated endocytosis. As clearly shown, the uptake of HA-MoS 2 conjugates was significantly reduced due to the competitive binding of HA in the HCT116 and B16F10 cells, whereas only slight change was observed in the HEK293 cells. These results confirmed the target-specific delivery of HA-MoS 2 conjugates via the HA receptor-mediated endocytosis.
In Vivo Bioimaging of HA-MoS 2 Conjugates
We carried out in vivo bioimaging of HA-MoS 2 conjugates in the tumor animal model of BALB/c nude mice inoculated with HCT116 cells. IVIS fluorescence imaging was performed after both subcutaneous (sc) and intravenous (iv) injections of HA-MoS 2 conjugates. We could observe the fluorescence signal of HA-MoS 2 conjugates at the injection site and confirm the feasibility of HA-MoS 2 conjugates for fluorescence bioimaging applications (Figure 5a ). After that, we further performed ex vivo bioimaging of PBS, PEG-MoS 2 conjugates as a control and HA-MoS 2 conjugates to investigate the tumor-targeting affinity and the whole body biodistribution (Figure 5b ). The fluorescence intensity was quantified in the region of interest (ROI) of dissected organs including lung, liver, kidney, spleen, and tumor (Figure 5c ). Since the fluorescence intensity of HA-MoS 2 conjugate was significantly higher than that of PEG-MoS 2 conjugates ( ** p < 0.01) in the tumor, we could confirm the effective target-specific delivery of HA-MoS 2 conjugates to the tumor. Remarkably, HA-MoS 2 conjugates appeared to accumulate in the primary tumor more than in the liver and kidney 24 h post-injection. The results might be caused by the HA receptor-mediated endocytosis with enhanced permeation of HA-MoS 2 conjugates and retention in the forms of the stacked MoS 2 within the cancer cells. [39, 40] Next, PA maximum amplitude projection (MAP) imaging of HA-MoS 2 conjugates was performed in tumor-bearing mice using an acoustic-resolution reflection mode PA imaging system at the wavelength of 680 and 850 nm for up to 4 h (Figure 5d-g The data showed 1860 folds higher enhancement of PA signals in average compared to the control at both wavelengths 1 h post-injection. Previously, traditional PA agents showed several hundred percent increase of PA signals after local injection. [41, 42] The results might be explained by the extremely high light-to-heat conversion efficiency of HA-MoS 2 conjugates. The PA amplitudes at both wavelengths were maintained even after 4 h, especially at the wavelength of 680 nm (Figure 5d ), in contrast to other organic PA agents with a short residence time. [43, 44] While there was no PA signal on the tumor before injection (Figure 5e ), the PA signal of HA-MoS 2 conjugates was clearly shown at the tumor site after intratumoral injection of HA-MoS 2 conjugates (Figure 5f,g ). From all these results, we could confirm the potential of HA-MoS 2 conjugates as a bimodal imaging contrast agent for in vivo fluorescence and PA imaging.
In Vivo Photothermal Cancer Therapy Using HA-MoS 2 Conjugates
Before in vivo therapeutic applications, we investigated the photothermal effect of HA-MoS 2 conjugates in HCT116 cells at conjugates without NIR laser illumination, the tumor tissues treated with HA-MoS 2 conjugates and NIR laser showed the significantly effective apoptosis of tumor cells (Figure 6f ). Finally, to further assess in vivo safety of HA-MoS 2 conjugates, we carried out histological analysis of dissected organs including lung, liver, spleen, and kidney ( Figure 6g ). There were no inflammation and histological difference after treatment with PBS and HA-MoS 2 conjugate, revealing the physiological safety of HA-MoS 2 conjugates. Taken together, we could confirm the feasibility of HA-MoS 2 conjugates for further multimodal cancer theranosis. For example, small chemical drugs can be loaded to the MoS 2 surface of HA-MoS 2 conjugates by π-π staking and hydrophobic interaction. [45, 46] Due to the high surface-to-volume ratio, MoS 2 might be served as a suitable drug carrier platform with high efficiency. It would be a noble approach to chemically and photothermally treat various cancer cells, such as MDA-MB-231 (human breast adenocarcinoma), Hela (human epithelioid cervix carcinoma), and B16F10 (musculus skin melanoma) cells. [29, 45] In addition, the lower cytotoxicity of exfoliated MoS 2 was reported than that of graphene and its analogues. [47] Furthermore, the upconversion property of HA-MoS 2 conjugates might be exploited for various applications to photomedicine in the deep tissue. [48] These are inspiring features of HA-MoS 2 conjugates for biomedical applications, enabling multimodal imaging and multimodal therapy of various cancer diseases. With more studies on the fundamental scientific background, HA-MoS 2 conjugate might open a new way to the futuristic multifunctional cancer theranosis.
Conclusions
Multifunctional HA-MoS 2 conjugates were successfully developed for multimodal bioimaging and PTT of cancers. MoS 2 nanoparticle could be easily surface modified with thiolated HA by simple mixing to enhance the biocompatibility, physiological stability, and tumor targeting efficiency. HA-MoS 2 conjugate showed the unique optical properties of upconversion and downconversion for fluorescence imaging and further applications to photomedicine. Noticeably, HA-MoS 2 conjugate appeared to be in situ cleaved in the reducing environment, enhancing the fluorescence signal and the photothermal effect. Using continuous and pulsed NIR, in vivo PAT and PTT were also effectively performed for the treatment of tumor-bearing mice. We believe our facile system of MoS 2 conjugated with HA can be successfully developed as a novel multifunctional theranostic nanoplatform for multimodal imaging and multimodal therapy of various cancer diseases.
Experimental Section
Exfoliation of MoS 2 : Dispersed MoS 2 nanomaterials were prepared using the simple aqueous exfoliation method as described elsewhere. [21] Briefly, 90 mg of bulk MoS 2 powder was dispersed in 30 mL of NMP, which was ultrasonicated (VCX750, Sonics Inc.) for 3 h. Then, the dispersion was transferred to a serum bottle and kept at 140 °C with vigorous stirring for 6 h. Afterwards, the suspension was centrifuged (1248R, Labogene) at 3000 rpm for 15 min. Finally, the brownish yellow supernatant containing MoS 2 was dialyzed using a cellulose membrane (MWCO = 3 kDa) against DI water for 2 days.
Preparation and Characterization of HA-MoS 2 and PEG-MoS 2 Conjugates: HA-SH was synthesized by the conjugation of cystamine to activated carboxyl group of HA with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and the following reduction with dithiothreitol (DTT). [20] HA-SH (1 mg mL −1 ) was added to MoS 2 (4 mg mL −1 ) in DI water, which was sonicated for 20 min. After that, the mixed solution was stirred overnight for the disulfide bond formation. PEG-MoS 2 conjugates were prepared using thiolated PEG (PEG-SH, MW = 10 kDa) as reported elsewhere. [13] After stirring, the mixture was filtered with a PD10 desalting column to remove the unreacted MoS 2 . The hydrodynamic size and Zeta-potential were measured by DLS (Zetasizer Nano, Malvern Instrument Co., UK). The chemical structure was analyzed by FT-IR (Nicolet 6700 FT-IR spectrometer, Thermo Fisher Sciengific Co., Waltham, MA). The UV-vis and PL spectra were obtained with a UV transilluminator (DUT-260, Core Bio System, Korea) and a fluorescence spectrometer (FP-6500, JASCO, Japan). The particle size and morphology were observed with an AFM (VEECO Instrument, New York, NY), a TEM (JEM-1011, JEOL, Japan), and an HR-TEM (JEM-2200FS with Cs-corrected TEM, JEOL, Japan). The binding energy spectrum was obtained by XPS (ESCA LAB250, VG scientific). Each sample for AFM and XPS analysis was prepared by drop casting of 0.1 mL solution on the clean silicon wafer. The sample placed wafer was dried in vacuum overnight. After that, the remaining solution was removed with a nitrogen air-gun.
Fluorescence Bioimaging of HA-MoS 2 Conjugates: Multicolor cellular imaging was performed using HCT116 cells seeded on an 8-chamber glass slide at a density of 2 × 10 4 cells per well for 24 h and cultured for 24 h. After that, the media were exchanged with serum-free media containing 40 µg mL −1 of HA-MoS 2 conjugates. The cells were incubated for 2 h, washed with PBS, fixed with 4% paraformaldehyde solution at room temperature for 10 min, washed again with PBS, and mounted with Vectashield mounting medium (Vector Laboratories, Inc., Burlingame, CA). Then, the cells were visualized with a confocal laser scanning microscope (Leica CM 1850 cryostat, Leica, Deerfield, IL) at different filter wavelengths of 415-480 nm, 496-563 nm, 570-637 nm, and 642-709 nm.
In vivo biodistribution of HA-MoS 2 conjugates was investigated to assess the tumor targeting affinity and the fluorescence imaging feasibility of HA-MoS 2 conjugates. Female mice inoculated with HCT116 cells on the dorsal skin were randomly divided into three groups and treated with: 1) PBS as a negative control, 2) PEG-MoS 2 conjugates as a positive control, and 3) HA-MoS 2 conjugates. All mice were fully anesthetized by intraperitoneal injection of a combination of ketamine (100 mg kg −1 ) and xylazine (10 mg kg −1 ). All mice were equally treated by the injection of 0.1 mL each sample at a concentration of 40 µg mL −1 to the jugular vein. At 4 h post-injection, all animals were sacrificed, and their lungs, livers, spleens, kidneys, and tumors were carefully dissected and washed with PBS for quantitative fluorescence imaging for the ROI using an IVIS imaging system (IVIS Spectrum) at an excitation wavelength of 465 nm and an emission wavelength filter of 520 nm, respectively. The relative fluorescence intensity of each organ was normalized to the total sum of the fluorescence in the organs. After ex vivo imaging, all organs were fixed in 4% formalin, embedded in paraffin, sectioned, H&E stained, and visualized by optical imaging microscopy (Olympus BX51M, Olympus, UK). The POSTECH institutional ethical protocols for animals were followed.
In Vitro Monitoring of Disulfide Cleavage in the Reducing Environment: The synthesized HA-MoS 2 conjugates were treated with TCEP at the same molar ratio of HA. After incubation for 24 h, the hydrodynamic diameter and Zeta-potential were measured by DLS. In addition, in vitro photothermal effect on the solution temperature change was assessed with and without TCEP treatment under NIR light illumination for 10 min. HiLyte647 dye was conjugated to HA chain as a fluorescent indicator for the intracellular monitoring of disulfide cleavage. In brief, HA-MoS 2 conjugates were mixed with 2 m excess of EDC and 4 mol% of HiLyte647 amine. After stirring for 2 h, the solution was dialyzed against 0.3 N NaCl aqueous solution and DI water to remove the remaining In vitro and in vivo PA images were obtained using acoustic-resolution reflection-mode PA imaging system. A Q-switched Nd:YAG laser (SLII-10; Continuum) at 532 nm wavelength was used for pumping a tunable OPO laser (Surelite OPOPLIS; Continuum), which provided a 5 ns pulse duration over the wavelength tuning range of 680-2500 nm at a 10 Hz repetition rate. To avoid PA signal generation from the surface, the illuminated laser beam had a donut-shaped pattern achieved by passing through a conical lens and an optical condenser. The pulsed laser energy was ≈5 mJ cm −2 . In vitro PA signals of both MoS 2 and HA-MoS 2 conjugates at the same optical density at 750 nm were measured from 680 to 950 nm. Each signal was normalized to the power of each laser. The wavelengths of 680 and 850 nm were used for in vivo PA imaging. The same methods and animal models were used for in vivo PTT described in the following section. A spherically focused ultrasonic transducer with a 5 MHz center frequency (V308; Olympus NDT) was applied for detecting the generated PA signals. A pulser/receiver (5072PR, Olympus NDT) and a digital oscilloscope (MSO 5204; Tektronix) were used for amplifying the PA signal and recoding, respectively. Two linear scanners were used to perform raster scanning to obtain volumetric PA imaging. As described above, female mice inoculated with HCT116 cells on the dorsal skin were treated by the injection of PBS or HA-MoS 2 conjugates. To improve the acoustic coupling efficiency, the mouse was put into a homemade water tank containing an ultrasound gel. The 5 MHz ultrasonic transducer induced axial and lateral resolutions of 145 and 950 µm, respectively. It took ≈30 min to acquire one 3D PA image.
Photothermal Ablation of HA-MoS 2 Conjugates: Using Dulbecco's modified Eagle medium (DMEM) supplemented with 10 vol% of FBS and 1 vol% of antibiotics, HCT116 cells were seeded on 96-well plates at a density of 6 × 10 3 cells per well in an incubator with 5% CO 2 atmosphere at 37 °C for 24 h. Then, HA-MoS 2 conjugates were dissolved in each cell medium at various concentrations from 0 to 200 µg mL −1 for 24 h. The antitumor effect of HA-MoS 2 conjugates was assessed by the standard MTT assay. The optical density was measured at 540 nm with a microplate reader (EMax microplate reader, Bucher Biotec AG, Basel, Switzerland). All photothermal ablation tests were performed using 808 nm NIR laser with a power density of 1 W cm −2 . In order for in vivo cancer PTT, HCT116 cells at a density of 5 × 10 6 in 100 µL were subcutaneously inoculated into both sides of dorsal skin of female BALB/c nude mice. After tumor growth to an average volume of 47.37 mm 3 for 10 days, 100 µL of PBS or HA-MoS 2 conjugates (100 µg mL −1 ) was intratumorally injected to the mice. Before injection, each mouse was fully anesthetized by intraperitoneal injection of a combination of ketamine (100 mg kg −1 ) and xylazine (10 mg kg −1 ). Then, the tumor site on each group was treated with or without NIR illumination for 10 min. A relative tumor volume was monitored using the following equation: tumor volume = A × B 2 /2 (A: maximum, B: minimum diameter of the tumor) and each tumor volume was divided by its original one. After 12 h, the photo-image of NIR light-treated region was taken with a digital camera (Samsung, Seoul, Korea), and all tumor sites were excised and fixed in 4% formaldehyde solution over 3 days for further histological and apoptosis analyses with TUNEL assay.
Statistical Analysis: Statistical analysis was performed via the t-test using the software of SigmaPlot10.0 (Systat Software Inc. San Jose, CA). Data were expressed as means ± standard deviation (SD) from several separate experiments. All experiments were done at least three times (n = 3). Figure 6b was analyzed by ANOVA test using the same software. The values for *p < 0.05 and **p < 0.01 were considered statistically significant.
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